DDPG in the news


In response to the recent Pfizer takeover bid for Astrazeneca the DDPG released a

letter that highlighted the changing drug discovery landscape in the UK and the effects on the science community. This led to considerable media interaction.  

 

Representatives of the DDPG published

a letter in the Financial Times highlighting the decline of the pharmaceutical industry in the UK. The Association of the British Pharmaceutical Industry (ABPI) published a response to this letter.

 



Further reading

 

Research Fortnight article written by David Phillips: Big pharma is broken, how can we fix it?

Research Fortnight article written by David Fox from the RSC: Keep making the tablets.

 

Research Fortnight article written by Mark Downs, chief executive of the Royal Society of Biology, Drug discoverers must adapt to a more complex world.

 

RSC News article,

Removing boundaries: Enabling the movement of researchers across disciplines and the industry-academia interface.

 

Comments from Mark Downs, chief executive of the Royal Society of Biology, recently featured in the Nature article

AstraZeneca juggernaut heads for Cambridge (£ - pay to view).